{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:31:12Z","timestamp":1770751872648,"version":"3.50.0"},"reference-count":46,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Background: Childhood cancers account for approximately 1\u20132% of all malignancies worldwide, with hematologic cancers representing about 35\u201340% of pediatric cases. Improved survival has brought increased recognition of both acute and long-term therapy-related complications, including secondary malignant neoplasms (SMNs). Survivors of pediatric hematologic malignancies face a lifelong risk of secondary malignant neoplasms (SMNs), which remain among the most severe late effects of therapy. Methods: We conducted a PRISMA 2020\u2013aligned systematic review of cohort and registry studies evaluating SMNs after childhood hematologic cancers. Databases searched included PubMed, Embase, Web of Science, Scopus, and Cochrane Library. Two reviewers independently screened studies, extracted data, and assessed risk of bias using the Newcastle\u2013Ottawa Scale; disagreements were resolved by a third reviewer. Results: Forty-three studies (&gt;70,000 survivors, median follow-up 5\u201330+ years) were included. Standardized incidence ratios (SIRs) for secondary malignant neoplasms compared to the general population ranged from 2.0 to 6.0, with absolute excess risks (AERs) of approximately 10\u201340 per 10,000 person-years. Therapy-related acute myeloid leukemia occurred within 5\u201310 years, while solid secondary malignant neoplasms (breast, thyroid, central nervous system, sarcomas) emerged after 10\u201325 years. The highest risks for developing secondary malignant neoplasms were observed among female survivors of Hodgkin lymphoma treated with chest and neck radiotherapy, particularly during adolescence, and among hematopoietic stem cell transplant recipients exposed to total body irradiation or chronic graft-versus-host disease. Conclusions: SMNs are predictable late effects requiring lifelong, exposure-anchored surveillance. Precision survivorship\u2014integrating treatment exposures, transplant conditioning, and genetic predisposition\u2014should guide future screening strategies.<\/jats:p>","DOI":"10.3390\/children13020205","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:00:47Z","timestamp":1770033647000},"page":"205","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Secondary Neoplasm in Survivors of Childhood Hematological Malignancies\u2014Systematic Review"],"prefix":"10.3390","volume":"13","author":[{"given":"Ioana-Alexandra","family":"Horne\u021b","sequence":"first","affiliation":[{"name":"Doctoral School of Medicine, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rgu Mure\u0219, Gheorghe Marinescu Street No. 38, 540136 T\u00e2rgu Mure\u0219, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreea Bianca","family":"Stoica","sequence":"additional","affiliation":[{"name":"Department of Pediatrics 1, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rgu Mure\u0219, Gheorghe Marinescu Street No 38, 540136 T\u00e2rgu Mure\u0219, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0113-6748","authenticated-orcid":false,"given":"Dora Mihaela","family":"C\u00eempian","sequence":"additional","affiliation":[{"name":"Department of Ethics and Social Sciences, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rgu Mure\u0219, 540139 T\u00e2rgu Mure\u015f, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucian","family":"Pu\u015fca\u015fiu","sequence":"additional","affiliation":[{"name":"Doctoral School of Medicine, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rgu Mure\u0219, Gheorghe Marinescu Street No. 38, 540136 T\u00e2rgu Mure\u0219, Romania"},{"name":"Department of Obstetrics and Gynecology 1, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rgu Mure\u0219, Gheorghe Marinescu Street No. 38, 540136 T\u00e2rgu Mure\u0219, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/jnci\/djad115","article-title":"Counts, Incidence Rates, and Trends of Pediatric Cancer in the United States, 2003\u20132019","volume":"115","author":"Siegel","year":"2023","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101662","DOI":"10.1016\/j.canep.2019.101662","article-title":"Childhood Cancer: Estimating Regional and Global Incidence","volume":"71","author":"Johnston","year":"2021","journal-title":"Cancer Epidemiol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Chavan, P.P., and Holmes, L. (2025). Pediatric Cancer Incidence, Temporal Trends, and Mortality in the United States by Health Disparities Indicators, SEER (1973\u20132014). Cancers, 17.","DOI":"10.3390\/cancers17172848"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Sultan, I., Alfaar, A.S., Sultan, Y., Salman, Z., and Qaddoumi, I. (2025). Trends in Childhood Cancer: Incidence and Survival Analysis over 45 Years of SEER Data. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0314592"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MOP.0000000000000984","article-title":"Global Health Disparities in Childhood Cancers","volume":"33","author":"Lubega","year":"2021","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_6","first-page":"100454","article-title":"Impact of Social Disparities on 10 Year Survival Rates in Paediatric Cancers: A Cohort Study","volume":"20","author":"Chalfant","year":"2023","journal-title":"Lancet Reg. Health\u2013Am."},{"key":"ref_7","unstructured":"Simone, J.V., Weiner, S.L., and Hewitt, M. (2003). Childhood Cancer Survivorship: Improving Care and Quality of Life, National Academies Press."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cncr.33922","article-title":"Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study: Occurrence of Cancer Types in Which Human Papillomavirus Is an Established Etiologic Risk Factor","volume":"128","author":"Henderson","year":"2022","journal-title":"Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/cncr.35041","article-title":"Pediatric Cancer Incidence Among Individuals with Overgrowth Syndromes and Overgrowth Features: A Population-Based Assessment in Seven Million Children","volume":"130","author":"Connolly","year":"2024","journal-title":"Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ricci, C., Subburaj, D., Lim, K., Shukla, N., Kaur, J., Xie, L., Laverty, M., Zakaria, D., Pole, J., and Pelland-Marcotte, M.-C. (2024). Second Malignant Neoplasms Within 5 Years from First Primary Diagnosis in Pediatric Oncology Patients in Canada: A Population-Based Retrospective Cohort Study. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1376652"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Upadhyay, R., Yadav, D., Venkatesulu, B.P., Singh, R., Baliga, S., Raval, R.R., Lazow, M.A., Salloum, R., Fouladi, M., and Mardis, E.R. (2022). Risk of Secondary Malignant Neoplasms in Children Following Proton Therapy vs. Photon Therapy for Primary CNS Tumors: A Systematic Review and Meta-Analysis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.893855"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/jnci\/djq238","article-title":"Subsequent Neoplasms in 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study","volume":"102","author":"Friedman","year":"2010","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1001\/jama.2011.747","article-title":"Long-Term Risks of Subsequent Primary Neoplasms Among Survivors of Childhood Cancer","volume":"305","author":"Reulen","year":"2011","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2217\/fca.12.44","article-title":"Cardiotoxicity in Childhood Cancer Survivors: Strategies for Prevention and Management","volume":"8","author":"Harake","year":"2012","journal-title":"Future Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1200\/JCO.2012.43.4951","article-title":"Yield of Screening for Long-Term Complications Using the Children\u2019s Oncology Group Long-Term Follow-Up Guidelines","volume":"30","author":"Landier","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1200\/JCO.2014.59.8052","article-title":"Collaborative Research in Childhood Cancer Survivorship: The Current Landscape","volume":"33","author":"Bhatia","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJMoa1510795","article-title":"Reduction in Late Mortality Among 5-Year Survivors of Childhood Cancer","volume":"374","author":"Armstrong","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2017.0693","article-title":"Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970\u20132015","volume":"317","author":"Turcotte","year":"2017","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"djx058","DOI":"10.1093\/jnci\/djx058","article-title":"Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer after Childhood Cancer","volume":"109","author":"Morton","year":"2017","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/S0140-6736(17)31610-0","article-title":"The Cumulative Burden of Surviving Childhood Cancer: An Initial Report from the St Jude Lifetime Cohort Study (SJLIFE)","volume":"390","author":"Bhakta","year":"2017","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1158\/1078-0432.CCR-16-0610","article-title":"Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors","volume":"23","author":"Sherborne","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1200\/JCO.2016.66.6545","article-title":"Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study","volume":"34","author":"Seidel","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1200\/JCO.20.00562","article-title":"Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer from the International Guideline Harmonization Group","volume":"38","author":"Mulder","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Chow, E.J., Ness, K.K., Armstrong, G.T., Bhakta, N., Yeh, J.M., Bhatia, S., Landier, W., Constine, L.S., Hudson, M.M., and Nathan, P.C. (2020). Current and Coming Challenges in the Management of the Survivorship Population, Elsevier.","DOI":"10.1053\/j.seminoncol.2020.02.007"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/pbc.22924","article-title":"The Current Status of Follow-Up Services for Childhood Cancer Survivors, Are We Meeting Goals and Expectations: A Report from the Consortium for New England Childhood Cancer Survivors","volume":"57","author":"Kenney","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/PPO.0b013e3181a1437a","article-title":"Role of Radiation Therapy in Hodgkin\u2019s Lymphoma","volume":"15","author":"Yahalom","year":"2009","journal-title":"Cancer J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/jama.2008.1039","article-title":"Breast Cancer Surveillance Practices Among Women Previously Treated with Chest Radiation for a Childhood Cancer","volume":"301","author":"Oeffinger","year":"2009","journal-title":"JAMA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1158\/1055-9965.EPI-11-0673","article-title":"Cancer Survivorship Research: A Review of the Literature and Summary of Current NCI-Designated Cancer Center Projects","volume":"20","author":"Harrop","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Hoeben, B.A., Wong, J.Y., Fog, L.S., Losert, C., Filippi, A.R., Bentzen, S.M., Balduzzi, A., and Specht, L. (2021). Total Body Irradiation in Haematopoietic Stem Cell Transplantation for Paediatric Acute Lymphoblastic Leukaemia: Review of the Literature and Future Directions. Front. Pediatr., 9.","DOI":"10.3389\/fped.2021.774348"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.20.02529","article-title":"Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study","volume":"39","author":"Peters","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/children2020146","article-title":"Secondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in Childhood","volume":"2","author":"Bomken","year":"2015","journal-title":"Children"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1038\/s41375-022-01693-z","article-title":"Incidence of Subsequent Malignancies After Total Body Irradiation-Based Allogeneic HSCT in Children with ALL\u2013Long-Term Follow-Up from the Prospective ALL-SCT 2003 Trial","volume":"36","author":"Eichinger","year":"2022","journal-title":"Leukemia"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/jnci\/djac125","article-title":"Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk Among Hodgkin Lymphoma Survivors","volume":"114","author":"Roberti","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/cas.15640","article-title":"Incidence of Second Primary Cancers Among Survivors of Childhood Cancer: A Population-Based Study, Osaka, Japan, 1975\u20132015","volume":"114","author":"Odani","year":"2023","journal-title":"Cancer Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jnci\/djy229","article-title":"Premature Aging in Young Cancer Survivors","volume":"111","author":"Armenian","year":"2019","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41408-024-01122-7","article-title":"Increased Risk of Subsequent Neoplasm After Hematopoietic Stem Cell Transplantation in 5-Year Survivors of Childhood Acute Lymphoblastic Leukemia","volume":"14","author":"Westerveld","year":"2024","journal-title":"Blood Cancer J."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Laddaga, F.E., Telegrafo, M., Garzillo, C., Fiorentino, A., Sardaro, A., Martinotti, S., Moschetta, M., and Gaudio, F. (2024). Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors: Evaluating Background Parenchymal Enhancement and Radiotherapy-Induced Toxicity. Cancers, 16.","DOI":"10.3390\/cancers16234091"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Ng, A.K., Kenney, L.B., Gilbert, E.S., and Travis, L.B. (2010). Secondary Malignancies Across the Age Spectrum, Elsevier.","DOI":"10.1016\/j.semradonc.2009.09.002"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jfma.2021.05.012","article-title":"Characteristics and Outcomes of Second Cancers in Patients with Childhood Cancer: A Report from the Taiwan Pediatric Oncology Group","volume":"121","author":"Ho","year":"2022","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1158\/1055-9965.EPI-16-0812","article-title":"Approach for Classification and Severity Grading of Long-Term and Late-Onset Health Events Among Childhood Cancer Survivors in the St. Jude Lifetime Cohort","volume":"26","author":"Hudson","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_41","first-page":"909","article-title":"Clinical Characteristics and Survival Patterns of Subsequent Sarcoma, Breast Cancer, and Melanoma After Childhood Cancer in the DCOG-LATER Cohort","volume":"30","author":"Teepen","year":"2019","journal-title":"Cancer Causes Control"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1200\/JCO.22.00574","article-title":"Health Benefits and Cost-Effectiveness of Children\u2019s Oncology Group Breast Cancer Screening Guidelines for Chest-Irradiated Hodgkin Lymphoma Survivors","volume":"41","author":"Wong","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_43","unstructured":"(2025, September 26). Children\u2019s Oncology Group Guidelines. Available online: https:\/\/www.survivorshipguidelines.org\/."},{"key":"ref_44","unstructured":"Aiuppa, L., Cartaxo, T., Spicer, C.M., Volberding, P.A., and National Academies of Sciences, Engineering, and Medicine (2020). Treatment Modalities for Childhood Cancers. Childhood Cancer and Functional Impacts Across the Care Continuum, National Academies Press."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jamaoncol.2024.6812","article-title":"The Children\u2019s Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers: A Review","volume":"11","author":"DeVine","year":"2025","journal-title":"JAMA Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/2\/205\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:52:49Z","timestamp":1770724369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/2\/205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["children13020205"],"URL":"https:\/\/doi.org\/10.3390\/children13020205","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]}}}